Search Results - "Mantha, Simon"

Refine Results
  1. 1

    Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism by Mantha, Simon, Ansell, Jack

    Published in Journal of thrombosis and thrombolysis (01-02-2015)
    “…Four target-specific oral anticoagulants (TSOA’s) have been compared to a vitamin K antagonist for the treatment of acute venous thromboembolism (VTE):…”
    Get full text
    Journal Article
  2. 2

    Whatʼs new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia? by Mantha, Simon, Tallman, Martin S, Soff, Gerald A

    Published in Current opinion in hematology (01-03-2016)
    “…PURPOSE OF REVIEWAcute promyelocytic leukemia (APL) is associated with a complex coagulopathy. In spite of substantial recent improvements in treatment…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot by Patell, Rushad, Zwicker, Jeffrey I, Singh, Rohan, Mantha, Simon

    Published in Bleeding, Thrombosis and Vascular Biology (01-01-2024)
    “…The goal of machine learning (ML) is to create informative signals and useful tasks by leveraging large datasets to derive computational algorithms. ML has the…”
    Get full text
    Journal Article
  6. 6

    Predictive factors of fatal bleeding in acute promyelocytic leukemia by Mantha, Simon, Tallman, Martin S., Devlin, Sean M., Soff, Gerald A.

    Published in Thrombosis research (01-04-2018)
    “…Acute promyelocytic leukemia (APL) is associated with a profound coagulopathy. Based on retrospective assessments, several potential risk factors for…”
    Get full text
    Journal Article
  7. 7

    Use of romiplostim for antineoplastic therapy-induced thrombocytopenia in gynecologic and breast cancers by Moufarrij, Sara, O'Cearbhaill, Roisin E., Zhou, Qin, Iasonos, Alexia, Mantha, Simon, Zwicker, Jeffrey, Wilkins, Cy R.

    Published in Gynecologic oncology reports (01-06-2024)
    “…•Chemotherapy-induced thrombocytopenia is common among patients with gynecologic or breast cancer during treatment.•64 % of patients with gynecologic or breast…”
    Get full text
    Journal Article
  8. 8

    Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer by Laube, Eva S., MD, Yu, Anthony, MD, Gupta, Dipti, MD, MPH, Miao, Yimei, BS, Samedy, Patrick, MS, Wills, Jonathan, BA, Harnicar, Stephen, PharmD, Soff, Gerald A., MD, Mantha, Simon, MD, MPH

    Published in The American journal of cardiology (27-04-2017)
    “…Abstract Rivaroxaban is broadly used for the primary prevention of stroke and systemic embolism in the general population with non-valvular atrial fibrillation…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance by Mantha, Simon, MD, MPH, Sarasohn, Debra, MD, Ma, Weining, MD, Devlin, Sean M., PhD, Chi, Dennis S., MD, Roche, Kara Long, MD, Suidan, Rudy S., MD, Woo, Kaitlin, MS, Soff, Gerald A., MD

    “…Objective Ovarian vein thrombosis is associated with pregnancy and pelvic surgery. Postpartum ovarian vein thrombosis is associated with infection and a high…”
    Get full text
    Journal Article
  11. 11

    Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use by Wilkins, Cy R., Ortiz, Jocelyn, Gilbert, Leah J., Yin, Shen, Mones, Jodi V., Parameswaran, Rekha, Mantha, Simon, Soff, Gerald A.

    “…Chemotherapy‐induced thrombocytopenia (CIT) is common during treatment with antineoplastic therapies and may adversely impact chemotherapy dose intensity…”
    Get full text
    Journal Article
  12. 12

    Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic by Mantha, Simon, Pianka, Ann Marie, Tsapatsaris, Nicholas

    Published in Journal of thrombosis and thrombolysis (01-10-2011)
    “…Oral anticoagulation with warfarin is widely used to treat venous and arterial thromboembolic disease (Ansell et al. Chest 133(6 suppl):160S–198S, 2008 ). Its…”
    Get full text
    Journal Article
  13. 13

    Cancer genetic alterations and risk of venous thromboembolism by Mantha, Simon, Rak, Janusz

    Published in Thrombosis research (01-05-2022)
    “…Cancer has long been known to incur an increased risk of venous thromboembolism (VTE). Multiple risk factors for cancer-associated thrombosis (CAT) have been…”
    Get full text
    Journal Article
  14. 14

    Dynamic Modelling for Cancer-Associated Venous Thromboembolism by Mantha, Simon, Singh, Rohan, Zwicker, Jeffrey I.

    Published in Blood (02-11-2023)
    “…Background: Cancer-associated venous thromboembolism (VTE) is an important source of morbidity and mortality. Current risk prediction models for thrombosis are…”
    Get full text
    Journal Article
  15. 15

    An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation by Mantha, Simon, Ansell, Jack

    Published in Thrombosis and haemostasis (01-09-2012)
    “…New oral anticoagulant drugs are emerging as alternatives to warfarin for the prevention of stroke in patients with non-valvular atrial fibrillation. Two…”
    Get more information
    Journal Article
  16. 16

    Prediction of COVID-19 Mortality in Patients with Cancer by Mantha, Simon, Jee, Justin, Soff, Gerald A., Pessin, Melissa S.

    Published in Blood (05-11-2020)
    “…Background: Coronavirus disease 2019 (COVID-19) is associated with an increased mortality rate in patients with cancer. Machine learning approaches have been…”
    Get full text
    Journal Article
  17. 17

    Target-specific oral anticoagulants in atrial fibrillation: results of phase III trials and comments on sub-analyses by Mantha, Simon

    Published in Journal of thrombosis and thrombolysis (01-08-2013)
    “…Dabigatran, rivaroxaban, apixaban and edoxaban administered in fixed doses and without routine laboratory monitoring have been compared to warfarin for the…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Indirect Comparison Of Dabigatran, Rivaroxaban and Apixaban For Venous Thromboembolic Disease by Mantha, Simon, Ansell, Jack

    Published in Blood (15-11-2013)
    “…Three target-specific oral anticoagulants (TSOA's) have been recently compared to standard therapy with a vitamin K antagonist (VKA) for the treatment of acute…”
    Get full text
    Journal Article
  20. 20

    Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study by Mantha, Simon, Miao, Yimei, Wills, Jonathan, Parameswaran, Rekha, Soff, Gerald A.

    Published in Journal of thrombosis and thrombolysis (01-05-2017)
    “…The development of thrombocytopenia in the setting of therapeutic anticoagulation for venous thromboembolic disease (VTE) is common in cancer patients, but…”
    Get full text
    Journal Article